Evgen Pharma PLC - Study started of new SFX-01 tablet formulation

RNS Number: 5254 G Evgen Pharma PLC 16 November 2022 Evgen Pharma plc. Study to investigate performance of new SFX-01 tablet formulation. Alderley Park, UK- 16 November 2022: Evgen Pharma plc, a clinical stage drug development company developing sulforaphane-based medicines announces that, further to the announcement on 12 November 2022, it has dosed the first...